Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder,
affecting 1 in 500 people in the general population. Although characterized by asymmetric …

Hypertrophic cardiomyopathy (HCM) is defined by structural and functional abnormalities of
the ventricular myocardium leading to increased left ventricular (LV) wall thickness. It was …

The classes of recommendations and levels of evidence in these guidelines were
determined and described according to the “Guidelines for the treatment of acute and …

Заболеваемость, смертность, а также частота отдаленных неблагоприятных исходов
психомоторного развития находится в обратной зависимости от гестационного …

Hypertrophic cardiomyopathy (HCM) in neonates is a rare and heterogeneous disorder
which is characterized by hypertrophy of heart with histological and functional disruption of …

Up to 14,500 young individuals die suddenly every year in Europe of cardiac pathologies.
The majority of these tragic events are related to a group of genetic defects that predispose …

To date limited data are available to predict the progression to end-stage heart failure (HF)
with subsequent death (non-SCD), need for heart transplantation, or sudden cardiac death …

Patients with hypertrophic cardiomyopathy (HCM) exhibit a variable phenotype with
ventricular hypertrophy as the cardinal manifestation and left ventricular (LV) outflow tract …

Aims Sudden cardiac death (SCD) is the most common mode of death in paediatric
hypertrophic cardiomyopathy (HCM). This study describes the implant and programming …

Objective Transaortic septal myectomy is the gold standard surgery in obstructive
hypertrophic cardiomyopathy, but it is not optimal for children aged less than 5 years and …